NCT03008824

Brief Summary

There is a rapidly escalating epidemic of obesity and type 2 diabetes across the world, with the fastest rise occurring in low- and middle-income countries. India not only has one of the highest rates in the world, but the disease starts at a younger age and lower levels of body weight than in UK white caucasians. Among city-dwelling Indians, approximately 8% of people aged 30-40 years already have diabetes. This is creating a heavy burden of disease and disability, and an intolerable economic burden through medical costs and lost earnings. Until now, efforts to prevent diabetes have mainly focussed on modifying the diet, lifestyle and activity of at-risk adults (for example those who are overweight, have a family history of diabetes or already have high blood sugar). However, recent research has indicated that factors acting in early life (during development in the womb) place an individual at risk of later diabetes. These include maternal malnutrition and low birthweight, and diabetes in the mother during pregnancy. Our research has shown that Indian mothers often have low vitamin B12 levels, which in turn causes high blood levels of a harmful metabolite (homocysteine). We have shown that these mothers get more diabetes in pregnancy. Their children are more likely to born with a low birth weight, and develop more body fat and higher plasma insulin levels during childhood, which are signs of higher diabetes risk in later life. The risk is increased further if the mother has normal or high status for another B vitamin, folate. Thus, we have shown, for the first time a link between a specific nutritional deficiency in the mother and diabetes risk in the next generation. One possible mechanism for the effect of maternal nutrition on risk of diabetes in her children is through epigenetic effects, whereby the nutritional environment during early development affects the switches that control gene expression. Since these switches are passed on via either parent, we think it is possible that paternal vitamin B12 status could also be important.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 4, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

January 4, 2017

Status Verified

December 1, 2016

Enrollment Period

4.8 years

First QC Date

December 22, 2016

Last Update Submit

December 29, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Differences in B12 levels between GDM and Controls

    5 Years

Secondary Outcomes (7)

  • Differences in B12 levels in South Asians and White Caucasians

    5 years

  • Differences between offspring birth weight between GDM and controls

    5 years

  • Differences between offspring adiposity between GDM and controls

    5 years

  • Differences between offspring birth weight between South Asians and White Caucasians

    5 years

  • Differences between offspring adiposity between South Asians and White Caucasians

    5 years

  • +2 more secondary outcomes

Other Outcomes (7)

  • Psychological impact of the diagnosis of GDM in each ethnicity

    5 years

  • Role of sedentary behavior on incident GDM

    5 years

  • Role of physical activity on incident GDM

    5 years

  • +4 more other outcomes

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All pregnant women between 18-75 years of age who satisfy NICE criteria for GDM screening

You may qualify if:

  • Pregnant women \<16 years of age
  • High risk for GDM (at least 1 of the risk factors) - BMI \>30
  • Previous GDM
  • First degree relatives with GDM
  • Previous unexplained still birth
  • Previous baby \>4.5kg
  • PCOS
  • Ethnic minority groups
  • Age \>35years

You may not qualify if:

  • Pregestational Type 1 or Type 2 Diabetes
  • Diagnosis of B12 or folate deficiency in the current pregnancy
  • Previous pregnancies with NTDs
  • Diagnosis of severe aneamia (\<10g/dL)
  • Vitamin B12 injections in the previous 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Warwick

Coventry, Coventry, CV47AL, United Kingdom

RECRUITING

Related Publications (1)

  • Saravanan P, Sukumar N, Adaikalakoteswari A, Goljan I, Venkataraman H, Gopinath A, Bagias C, Yajnik CS, Stallard N, Ghebremichael-Weldeselassie Y, Fall CHD. Association of maternal vitamin B12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study). Diabetologia. 2021 Oct;64(10):2170-2182. doi: 10.1007/s00125-021-05510-7. Epub 2021 Jul 22.

Biospecimen

Retention: SAMPLES WITH DNA

Plasma, serum and whole blood for isolating DNA

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Ponnusamy Saravanan, FRCP PhD

    University of Warwick

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ponnusamy Saravanan, FRCP PhD

CONTACT

Amitha Gopinath, MBA

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Clinical Professor

Study Record Dates

First Submitted

December 22, 2016

First Posted

January 4, 2017

Study Start

September 1, 2012

Primary Completion

June 1, 2017

Study Completion

June 1, 2018

Last Updated

January 4, 2017

Record last verified: 2016-12

Locations